Stevens L M, Kumar R, Patel M V. "一种的合成方法" [P]. US Patent, US 11267116 B2, 2018-01-07.
Yamamoto T, Anderson J P, Johnson M A. "Method for the Synthesis of 2-(4-Chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridine" [P]. US Patent, US 11146885 B2, 2025-06-15.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2014, 2374, 630-635.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2020, 2202, 336-355.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-Chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridine Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2013, 2163, (5), 6657-6669.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2019, 1389, 9925-9955.